FDA links rare cancer, 9 deaths, to textured breast implants
The U.S. Food and Drug Administration says it has received reports of 9 deaths and more than 350 cases of a rare blood cancer linked to breast implants.
The FDA said Tuesday it now agrees with the World Health Organization, which concluded years ago this type of lymphoma can develop following breasts implants.
Concerns were first raised at the FDA in 2011, but the agency said then that there were too few cases to know if there was a connection.
The disease seems to occur more often with textured implants in the scar tissue near the implant and is associated with pain and swelling sometimes years after the surgery has healed.
The FDA said it can't determine how many cases there are, but noted Australia has also reported three deaths.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Tiger fans have mixed emotions about tailgating during the pandemic
Researchers find pandemic's impact on mental health, chronic health conditions beyond virus
LSU reconsidering plans for virtual commencement after student backlash
Alcohol sales return to Tiger Stadium for LSU's second home game Saturday
La. legislature files petition to end governor's COVID restrictions